Chen Yi, Yang Xiaoxu, Chen Jiaoyang, Yang Xiaoling, Yang Ying, Liu Aijie, Zhang Xiaoli, Wu Wenjuan, Sun Dan, Yang Zhixian, Jiang Yuwu, Zhang Yuehua
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Center for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China.
Front Neurol. 2022 Nov 3;13:1041509. doi: 10.3389/fneur.2022.1041509. eCollection 2022.
To analyze the genotypes and phenotypes of mosaic male patients with -related epilepsy (-RE) and explore the correlation between genotype, variant allele frequency (VAF), and phenotypic severity.
Clinical data and peripheral blood samples of 11 male mosaic patients were collected and analyzed in our study. The VAF of the gene from peripheral blood was quantified using amplicon-based deep sequencing. Additional 20 mosaic male patients with -RE were collected from the published literature, with 10 patients whose VAFs of the gene were available for analytic purposes.
In our cohort of 11 patients, 10 variants were identified, and four were novel. The VAF of the gene from peripheral blood ranged from 27 to 90%. The median seizure onset age was 6 months (range: 4-9 months). Clinical manifestations included cluster seizures (100%), fever sensitivity (73%), focal seizures (91%), developmental delay/intellectual disability (DD/ID, 82%), and autistic features (45%). Thirty-one mosaic male patients collected from our cohort and the literature developed seizures mostly (87%) within one year of age. Variant types included missense variants (42%), truncating variants (52%), splice variants (3%), and whole deletion (3%). Among 21 patients with a definite VAF from our cohort and the literature, nine had a low VAF ( ≤ 50%) and 12 had a high VAF (> 50%). Seventy-five percent of variants from the high VAF group were missense, whereas 89% of those from the low VAF group were truncations. The median seizure onset age was 6 months in the low VAF group and 9 months in the high VAF group ( = 0.018). Forty-four percent (4/9) of patients from the low VAF group achieved seizure-free for ≥1 year, whereas none of the 12 patients from the high VAF group did ( = 0.021). DD/ID was present in 83% (10/12) of the high VAF group and 56% (5/9) of the low VAF group ( = 0.331).
The predominant variant types were truncating and missense variants. Missense variants tended to have higher VAFs. Patients with a high VAF were more likely to have a more severe epileptic phenotype. Our findings shed light on the phenotypic implications of VAF in mosaic males with -RE.
分析与相关癫痫(-RE)的嵌合型男性患者的基因型和表型,并探讨基因型、变异等位基因频率(VAF)与表型严重程度之间的相关性。
本研究收集并分析了11例男性嵌合型患者的临床资料和外周血样本。使用基于扩增子的深度测序对外周血中基因的VAF进行定量分析。另外从已发表的文献中收集了20例患有-RE的嵌合型男性患者,其中10例患者的基因VAF可用于分析。
在我们的11例患者队列中,共鉴定出10种变异,其中4种为新变异。外周血中基因的VAF范围为27%至90%。癫痫发作的中位起始年龄为6个月(范围:4至9个月)。临床表现包括丛集性发作(100%)、发热敏感性(73%)、局灶性发作(91%)、发育迟缓/智力残疾(DD/ID,82%)和自闭症特征(45%)。从我们的队列和文献中收集的31例嵌合型男性患者大多(87%)在1岁内出现癫痫发作。变异类型包括错义变异(42%)、截短变异(52%)、剪接变异(3%)和整个基因缺失(3%)。在我们的队列和文献中21例有明确VAF的患者中,9例VAF较低(≤50%),12例VAF较高(>50%)。高VAF组中75%的变异为错义变异,而低VAF组中89%的变异为截短变异。低VAF组癫痫发作的中位起始年龄为6个月,高VAF组为9个月(P = 0.018)。低VAF组44%(4/9)的患者癫痫发作缓解≥1年,而高VAF组12例患者中无一例达到该情况(P = 0.021)。高VAF组83%(10/12)的患者存在DD/ID,低VAF组为56%(5/9)(P = 0.331)。
主要的变异类型为截短变异和错义变异。错义变异往往具有较高的VAF。VAF较高的患者更有可能具有更严重的癫痫表型。我们的研究结果揭示了VAF在患有-RE的嵌合型男性中的表型意义。